Literature DB >> 15850368

Manifestations of hereditary multiple exostoses.

Jonathan R Stieber1, John P Dormans.   

Abstract

The solitary osteochondroma, a common pediatric bone tumor, is a cartilage-capped exostosis. Hereditary multiple exostosis is an autosomal dominant disorder manifested by the presence of multiple osteochondromas. Linkage analysis has implicated mutations in the EXT gene family, resulting in an error in the regulation of normal chondrocyte proliferation and maturation that leads to abnormal bone growth. Although exostoses are benign lesions, they are often associated with characteristic progressive skeletal deformities and may cause clinical symptoms. The most common deformities include short stature, limb-length discrepancies, valgus deformities of the knee and ankle, asymmetry of the pectoral and pelvic girdles, bowing of the radius with ulnar deviation of the wrist, and subluxation of the radiocapitellar joint. For certain deformities, surgery can prevent progression and provide correction. Patients with hereditary multiple exostosis have a slight risk of sarcomatous transformation of the cartilaginous portion of the exostosis.

Entities:  

Mesh:

Year:  2005        PMID: 15850368     DOI: 10.5435/00124635-200503000-00004

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  65 in total

1.  A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses.

Authors:  Kazu Matsumoto; Fumitoshi Irie; Susan Mackem; Yu Yamaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Factors affecting outcomes in patients treated surgically for upper extremity tumors and tumor-like lesions.

Authors:  Jesse E Otero; Christopher M Graves; Ashley TeKippe; Joseph A Buckwalter; Benjamin J Miller
Journal:  Iowa Orthop J       Date:  2013

Review 3.  [Cartilage tumors. Classification, conditions for biopsy and histologic characteristics].

Authors:  G Delling; B Jobke; S Burisch; M Werner
Journal:  Orthopade       Date:  2005-12       Impact factor: 1.087

4.  Costal osteochondroma spicule associated with pleural effusion.

Authors:  James Chen; Scott Nelson; Brian Tzung; Harry Applebaum; Daniel A DeUgarte
Journal:  Pediatr Surg Int       Date:  2013-05-08       Impact factor: 1.827

Review 5.  Genetic alterations in chondrosarcomas - keys to targeted therapies?

Authors:  Andre M Samuel; Jose Costa; Dieter M Lindskog
Journal:  Cell Oncol (Dordr)       Date:  2014-01-24       Impact factor: 6.730

Review 6.  Glycobiology and the growth plate: current concepts in multiple hereditary exostoses.

Authors:  Kevin B Jones
Journal:  J Pediatr Orthop       Date:  2011 Jul-Aug       Impact factor: 2.324

7.  Enigmatic cranial superstructures among Chamorro ancestors from the Mariana Islands: gross anatomy and microanatomy.

Authors:  Gary M Heathcote; Timothy G Bromage; Vincent J Sava; Douglas B Hanson; Bruce E Anderson
Journal:  Anat Rec (Hoboken)       Date:  2014-04-18       Impact factor: 2.064

8.  Multiple hereditary exostoses and stroke due to vertebral artery dissection.

Authors:  Antonio Arauz; Bernardo Hernández-Curiel; Jonathan Colin-Luna; David J Dávila-Ortiz de Montellano; Miguel A Barboza
Journal:  J Vasc Interv Neurol       Date:  2015-02

9.  The type 2 diabetes associated rs7903146 T allele within TCF7L2 is significantly under-represented in Hereditary Multiple Exostoses: insights into pathogenesis.

Authors:  Federica Sgariglia; Elena Pedrini; Jonathan P Bradfield; Tricia R Bhatti; Pio D'Adamo; John P Dormans; Aruni T Gunawardena; Hakon Hakonarson; Jacqueline T Hecht; Luca Sangiorgi; Maurizio Pacifici; Motomi Enomoto-Iwamoto; Struan F A Grant
Journal:  Bone       Date:  2014-12-09       Impact factor: 4.398

10.  Cervical osteochondroma presenting as brown-sequard syndrome in a child with hereditary multiple exostosis.

Authors:  In-Ho Han; Sung-Uk Kuh
Journal:  J Korean Neurosurg Soc       Date:  2009-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.